EUVIMEDEUVIMED entdecken
Open Access

A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers

Qingqing Shen, Jie Pu, Chao Xue, Ming Zhang, Yang Qu, Shihan Huo iD, Michael Belford, Charles Maxey, Neloni Wijeratne, Claudia Martins, Scott Peterman, Wei-Jun Qian iD und 2 weitere

Analytical Chemistry · 2024

DOI: 10.1021/acs.analchem.4c01888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Qingqing Shen und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases, Center for Protein Therapeutics, University at Buffalo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sensitivity of LC-MS in quantifying target proteins in plasma/tissues is significantly hindered by coeluted matrix interferences. While antibody-based immuno-enrichment effectively reduces interferences, developing and optimizing antibodies are often time-consuming and costly. Here, by leveraging the orthogonal separation capability of Field Asymmetric Ion Mobility Spectrometry (FAIMS), we developed a FAIMS/differential-compensation-voltage (FAIMS/dCV) method for antibody-free, robust, and ultrasensitive quantification of target proteins directly from plasma/tissue digests. By comparing the intensity-CV profiles of the target vs coeluted endogenous interferences, the FAIMS/dCV approach identifies the optimal CV for quantification of each target protein, thus maximizing the signal-to-noise ratio (S/N). Compared to quantification without FAIMS, this technique dramatically reduces endogenous interferences, showing a median improvement of the S/N by 14.8-fold for the quantification of 17 representative protein drugs and biomarkers in plasma or tissues and a 5.2-fold median increase in S/N over conventional FAIMS approach, which uses the peak CV of each target. We also discovered that the established CV parameters remain consistent over months and are matrix-independent, affirming the robustness of the developed FAIMS/dCV method and the transferability of the method across matrices. The developed method was successfully demonstrated in three applications: the quantification of monoclonal antibodies with subng/mL LOQ in plasma, an investigation of the time courses of evolocumab and its target PCSK9 in a preclinical setting, and a clinical investigation of low abundance obesity-related biomarkers. This innovative and easy-to-use method has extensive potential in clinical and pharmaceutical research, particularly where sensitive and high-throughput quantification of protein drugs and biomarkers is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAnimalsHumansIon Mobility SpectrometryChromatography, LiquidProteinsMass SpectrometryMicePharmaceutical Preparations

Substanzen

BiomarkersProteinsPharmaceutical Preparations

Autor:innen und Institutionen

  • The Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, New York 14214, United States.
  • Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Summit, New Jersey 07901, United States.
  • Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, New York 14214, United States.
  • New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States.
  • Thermo Fisher Scientific, San Jose, California 95134, United States.
  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.

ORCID-Profile: Shihan Huo, Wei-Jun Qian, Jun Qu

Förderung

  • NIDDK NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases
  • Center for Protein Therapeutics, University at Buffalo

Zitieren

APA

Shen, Q., Pu, J., Xue, C., Zhang, M., Qu, Y., Huo, S., Belford, M., Maxey, C., Wijeratne, N., Martins, C., Peterman, S., Qian, W. J., Boeser, C., & Qu, J. (2024). A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c01888

Vancouver

Shen Q, Pu J, Xue C, Zhang M, Qu Y, Huo S, et al. A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c01888

BibTeX
@article{Shen2024,
  author = {Shen, Qingqing and Pu, Jie and Xue, Chao and Zhang, Ming and Qu, Yang and Huo, Shihan and Belford, Michael and Maxey, Charles and Wijeratne, Neloni and Martins, Claudia and Peterman, Scott and Qian, Wei-Jun and Boeser, Cornelia and Qu, Jun},
  title = {A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers},
  journal = {Analytical Chemistry},
  year = {2024},
  doi = {10.1021/acs.analchem.4c01888}
}
Kostenlos starten →